MedPath

GreenGlo

Green Glo (Lissamine Green)

Approved
Approval ID

16a8622b-b349-4b10-b45a-f1f1551b2b06

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 1, 2024

Manufacturers
FDA

HUB Pharmaceuticals, Inc.

DUNS: 611747945

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lissamine Green

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code17238-920
Product Classification
G
Generic Name
Lissamine Green
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateJanuary 1, 2024
FDA Product Classification

INGREDIENTS (1)

LIGHT GREEN SF YELLOWISHActive
Quantity: 1.5 mg in 1.5 mg
Code: 3F7BHA64Z0
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GreenGlo - FDA Drug Approval Details